4:06 PM ET
8-K
Business Update
Citius Pharmaceuticals Business Update
Citius Pharmaceuticals' subsidiary, Citius Oncology, reported preliminary fiscal fourth quarter 2026 operational metrics for its drug LYMPHIR. The company saw a 120% increase in unit sales to wholesalers (792 units) and expanded its institutional reach to 54 ordering centers as it works toward a goal of 100 priority institutions by year-end.
- Term
- Q4 2026